Skip to main content
SpringerLink
Log in

Adefovir Dipivoxil

Bis-POM PMEA, GS 0840, GS 840, Piv2PMEA

  • Section 1: Cytomegalovirus Retiniti
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cundy KC, Fishback JA, Shaw J-P, et al. Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys. Pharm Res 1994 Jun; 11: 839–43

    Article  PubMed  CAS  Google Scholar 

  2. Barditch-Crovo P, Toole J, Hendrix CW, et al. Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patients. J Infect Dis 1997 Aug; 176: 406–13

    Article  PubMed  CAS  Google Scholar 

  3. Barditch-Crovo PA, Cundy KC, Wachsman M, et al. Pharmacokinetic profile of 9-[2-(bispivaloyloxy-methyl) phosphonylmethoxy] adenine (bis-POM PMEA), an orally bioavailable prodrug of the antiviral nucleotide, PMEA. 2nd National Conference Human Retroviruses and Related Infections 1995 Jan 29–Feb 2; Washington, DC, 145

    Google Scholar 

  4. Cundy KC, Barditch-Crovo P, Walker RE, et al. Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients. Antimicrob Agents Chemother 1995 Nov; 39: 2401–5

    Article  PubMed  CAS  Google Scholar 

  5. Deeks SG, Collier A, Lalezari J, et al. The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. J Infect Dis 1997 Dec; 176: 1517–23

    Article  PubMed  CAS  Google Scholar 

  6. Gilead Sciences Inc. Gilead Sciences announces statistically significant data from phase II/III study of Preveon for the treatment of patients with HIV infection [press release]. 1998 Apr 6. URL: http://www.gilead.com [Accessed 1998 Apr 6]

    Google Scholar 

  7. Kahn J, Lagakos S, Weng D, et al. Amulti-center, randomized, double-blind placebo controlled study of the efficacy and safety of adefovir dipivoxil when added to standard antiretroviral therapy. AIDS 1998 Nov; 12 Suppl. 4: 13

    Google Scholar 

  8. Naesens L, Neyts J, Balzarini J, et al. Antiviral efficacy in mice of oral bis(POM)-PMEA, the bis (pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine. Antiviral Res 1995 Mar; 26: A276

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adefovir Dipivoxil. Drugs R&D 2, 303–305 (1999). https://doi.org/10.2165/00126839-199902050-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902050-00003

Keywords

Search

Navigation